About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6182 record(s)
Req # A-2024-000010
Health Canada's assessment of the potential yearly healthcare costs that could be saved by Canada's Medical Assistance in Dying program.Organization: Health Canada
April 2024
Req # A-2024-000071
Records of communication between employees or appointed politicians working collaboratively with or for Health Canada, and staff or appointed politicians in the New Zealand Government regarding sodium monofluoroacetate. Between January 1, 2021 and April 18, 2024.Organization: Health Canada
April 2024
Req # A-2020-000450
Adverse Drug Reaction (ADR). Report number: E2B_03076104.Organization: Health Canada
April 2024
Req # A-2020-000938
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108812-88, Deputy Minister’s Meeting with Canada’s new Auditor General.Organization: Health Canada
April 2024
Req # A-2020-001030
Adverse Drug Reactions (ADRs). Report numbers: 000721620, 000721621, 000721623, 000721654, 000721705, 000721791, 000721858, 000721859, 000722031, 000722048, 000722071, 000722086, 000722112, 000722119, 000722122, 000722123, 000722145, 000722159, 000722166, 000722199.Organization: Health Canada
April 2024
Req # A-2020-001430
Adverse Drug Reactions (ADRs). Report numbers: E2B_02959763, E2B_02959832, E2B_02959837, E2B_02960718, E2B_02961718, E2B_02961975, E2B_02962182, E2B_02962222, E2B_02962228, E2B_02962240, E2B_02962267, E2B_02962383, E2B_02962725, E2B_02962736, E2B_02962739, E2B_02962741, E2B_02962742, E2B_02962746, E2B_02962752, E2B_02962762.Organization: Health Canada
April 2024
Req # A-2020-001535
Adverse Drug Reactions (ADRs). Report numbers: E2B_03106484, E2B_03107034, E2B_03107273, E2B_03107558, E2B_03107824, E2B_03108501, E2B_03109625, E2B_03110378, E2B_03110399, E2B_03110511, E2B_03110611, E2B_03110675, E2B_03111060, E2B_03111289, E2B_03111329, E2B_03111356, E2B_03111361, E2B_03111425, E2B_03111555, E2B_03111769.Organization: Health Canada
April 2024
Req # A-2020-001610
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114416-734.Organization: Health Canada
April 2024
Req # A-2021-000028
Adverse Drug Reactions (ADRs). Report numbers: 000928579, E2B_01441318, E2B_03408201, E2B_03408205, E2B_03408767, E2B_03408772, E2B_03409939, E2B_03419846, E2B_03421929, E2B_03422163, E2B_03440717, E2B_03442217, E2B_03443245, E2B_03451400, E2B_03451572, E2B_03455168, E2B_03455178, E2B_03456254, E2B_03456776, E2B_03467997.Organization: Health Canada
April 2024
Req # A-2021-000404
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105904-139, Proposed Critical Drug Reserve Procurement Action.Organization: Health Canada
April 2024